The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.4 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Evoq Remedies Ltd (Scrip Code: 543500) has disclosed that promoter Bhumishth Narendrabhai Patel sold 5,36,000 equity shares on 21st October 2025 through the Stock Exchange. Before the sale, he held 5,39,574 shares representing 2.17% of the company's share capital. After the disposal, his holding has dropped to just 3,574 shares, or 0.02% of total equity. The transaction was carried out in the open market, and the company's total equity capital remains unchanged at 2,49,00,000 shares of Rs. 10 each (Rs. 24.9 crore).
This near-complete exit by a promoter (from 2.17% to 0.02%) may be viewed negatively by retail investors as it signals reduced promoter skin in the game. The stock could see short-term pressure given the scale of the offloading.